The Wnt/β-catenin signaling pathway plays a crucial role in carcinogenesis as well as development (1) (2) (3) (4) . The implication of Wnt/β-catenin signaling in carcinogenesis has been attributable to aberrant regulation of this pathway as a result of mutations of β-catenin, adenomatous polyposis coli (Apc), and/or Axin. Thus, mutations of these genes have been described in many types of human cancers such as hepatocellular carcinoma (HCC) (5) (6) (7) (8) and human colorectal cancer (CRC) (4, (9) (10) (11) . Because Apc and Axin play pivotal roles in the control and stability of β-catenin (12) (13) (14) (15) , functional alterations of these proteins can lead to accumulation of β-catenin in the nucleus and increased transcription of β-catenin/Tcf-responsive genes (16, 17) . Based on these findings, mutations that constitutively stabilize and activate β-catenin are likely to be involved in malignant transformation. The ERK pathway is also a major transforming pathway, and the aberrant activation of the ERK pathway by oncogenic mutation(s) such as ras mutation results in human cancers, including CRC and HCC (18) (19) (20) . Although deregulation of both the Wnt/β-catenin and ERK pathways can lead to transformation, the interaction of the two pathways during tumorigenesis is poorly understood.
The potential tumor formation by K-ras mutation was significantly inhibited in cells retaining wild-type Apc (21) . Subsequent studies have shown that β-catenin can cooperate with ras in neoplastic transformation (22, 23) . Furthermore, studies utilizing colorectal cancer cell lines demonstrated that ras-induced proliferation and transformation were reduced by overexpression of Apc (24) . Although these studies imply an interaction between the Wnt/β-catenin and ERK signaling pathways in carcinogenesis, a mechanism and in vivo evidence for the interaction is lacking.
In this study, we investigated the relationship between the Wnt/β-catenin and the ERK pathways by measuring the effects of Axin induction using stable L929 fibroblast cells retaining doxycyclin (Dox)-inducible Axin (L929-Axin). Axin, a negative regulator of Wnt/β-catenin signaling, was identified as an inhibitor of the Raf-1 MEK ERK cascade in fibroblasts, which finding was also revealed in primary hepatocytes and several cancer cells. β-catenin was identifiable as a mediator in ERK pathway regulation by Axin, which regulation was investigated by measurements of Axin overexpression on activation of the ERK pathway components in different types of cells that retained either a mutated or functionally active wild-type GTP-loading capacities of both mutant and wildtype Ras were reduced by Axin overexpression. The reductions of GTP-loading of nonhydrolysable mutant ras (25) was found to be attributable to the reduction of the ras protein level by Wnt/β-catenin signaling. The Ras regulation by Axin overexpression was abolished by treatment of leupeptin, the lysosomal inhibitor, indicating involvement of the lysosomal protein degradation machinery in the regulation of the Ras protein level.
Axin inhibits ERK pathway activation stimulated either by EGF or Ras, and that at least partly via reduction of Ras protein level. The Ras-ERK pathway inhibition by Axin occurs in a β-catenin-dependent manner, and that related with the regulation of cellular proliferation. The roles of β-catenin in the regulation of Ras and the ERK pathway components were clearly indicated by the measured effects of the knock down of nondegradable mutant β-catenin. The role of β-catenin in Ras regulation was further indicated by the lack of effect of Axin induction in cells overexpressing β-catenin S33Y, a non-degradable β-catenin. Axin can affect Ras at the levels both of GTP-loading and protein regulation. The role of EGFR in the regulation of Ras by Axin was indicated by the measured effects of EGFR siRNA. The functional point of Axin was further defined as occurring upstream of Raf by loss of the antiproliferative role of Axin in cells overexpressing Raf-1-CAAX (26) , an active form of Raf.
The role of Axin as the anti-transforming factor involving ERK pathway regulation was revealed by inhibition of the anchorage-independent cellular growth by EGF or oncogenic Ras in cells expressing Axin. The identification of Ras-ERK pathway regulation by Wnt/β-catenin signaling provides evidence for interaction between the Wnt/β-catenin and ERK pathways in carcinogenesis.
In addition, this study also contributes to resolving the uncertainty in previous observations of a functional synergism between ras and β-catenin in carcinogenesis.
EXPERIMENTAL PROCEDURES
Plasmids-The expression vector for Axin, pCS2-MT-Axin, and inducible expression vectors for GFP (pBI-EGFP) and GFP-Axin (pBI-EGFPAxin) were described in previous studies (14, 25) .
The Flag-β-catenin-pcDNA3.0, pMT3-Ras L61 , pFR-Luc, and pFA2-Elk1 plasmids were described in a previous study (24) . To construct a vector for Axin siRNA production (pAxin-siRNA), two oligomers containing the 19-nucleotide target sequences (5'-GAT CCC AGT ACA TCC TGG  ATA GCA ATT CAA GAG ATT GCT ATC  CAG GAT GTA CTT TTT TTG GAA A-3' and  5'-AGC TTT TCC AAA AAA AGT ACA TCC  TGG ATA GCA ATC TCT TGA ATT GCT ATC CAG GAT GTA CTG G-3') of the murine Axin gene (nts 827-849; GenBank accession number AF009011) were annealed and ligated into the BglII and HindIII sites of the pSUPER vector (27) . pZIP-Raf-CCAX (26) and Flag-S33Y-β-cateninpcDNA3.0 (28) were kindly provided by Drs. C. J. Marshall at the Institute of Cancer Research, UK, and Eric R. Fearon of the University of Michigan, U.S.A., respectively.
Axin-inducible Fibroblasts and Preparation of Cells-To establish GFP (L929-GFP) and GFPAxin (L929-GFP-Axin), inducible L929 cells were co-transfected with either pBI-EGFP or pBI-EGFP-Axin with rtTA2SM2-Neo at a 1:3 molar ratio using Superfect Transfection Reagent (Qiagen). Stably transfected clones were selected in a medium containing 800 μg/ml of G418 (Invitrogen, Carlsbad, CA) and individual G418-resistant clones were isolated in cloning dishes (Sigma, St. Louis, MO). L929-GFP-Axin cells were grown in Dulbecco's Modified Eagle Medium (DMEM) supplemented with 10% heatinactivated fetal bovine serum (FBS), G418 (200 μg/ml), streptomycin (100 μg/ml), and penicillin G sodium (100 μg/ml) and incubated at 37 o C in 5% CO 2 . Axin was induced by 0.5 μg/ml of Dox (Sigma) and/or stimulated with 20 ng/ml of EGF (Cell Signaling Biotechnology). For observation of cell morphological changes, L929-Axin-GFP cells and L929-GFP cells were seeded into 6-well plates at 4 × 10 4 cells/well and cultured at 37 o C in 5% CO 2 for 24 h. The GFP-expressed cells were induced for 24 h by treatment with 0.5 μg/ml of Dox. After induction, the cells were examined under a phase-contrast fluorescence microscope (Nikon, TE-2000U, Japan) for visualization of morphology and expression of GFP or Axin-GFP. DLD-1, HCT-116, and SW-480 colorectal cancer cells, and Chang normal liver and HepG2 hepatoma cancer cells were obtained from the American Type Culture Collection and cultured as previously described (24) . NIH3T3 cells containing Dox-inducible H-ras G12R were also described in previous study (24) . DLD-1, HCT-116, SW480, Chang, HepG2, L929, and NIH3T3 cells were seeded at 3 × 10 5 cells per 100 mm dish. After growth for 24 h, cells were transfected with plasmids using Lipofectamine Plus reagent according to the manufacturer's instructions (Invitrogen, Carlsbad, CA), and then harvested at 24 h thereafter. Cells were rinsed twice with icecold PBS, harvested, and then lysed using radioimmunoprecipitation assay (RIPA) buffer (Upstate, Lake Placid, NY) in order to determine the protein concentrations.
Primary Cells-Rat primary hepatocytes were isolated using the collagenase perfusion method (29) . The portal vein was catheterized with a 22 GA Angiocath, and following perfusion of the liver with collagenase buffer, the liver was removed and shredded for isolation of hepatocytes. The hepatocytes were then washed 3 times with cold serum free DMEM. Hepatocytes (1.5 × 10 6 ) were seeded onto 60 mm dishes coated with collagen IV (BD Biosciences, Bedford, MA) and cultured in DMEM with 10% FBS, streptomycin (100 μg/ml), and penicillin G sodium (100 μg/ml) then incubated at 37 ℃ in 5% CO 2 . To examine the effects of Axin and/or EGF, cells were transiently transfected with pCS2-MT-Axin and/or were treated with 20 ng/ml EGF. The cells were harvested at 24 h after transfection and subjected to Western blot analysis.
β-Catenin and EGFR siRNAs and
Treatment-β-catenin (Gene bank accession number NM_001904) and EGFR (NM_207655) mRNA target sequences were designed using an siRNA template design tool (Ambion, Austin, TX), and siRNA was prepared with a Silencer TM siRNA construction kit (Ambion), as described previously (24 Western Blot Analysis-Western blot analysis was performed as previously described (7) . AntiAxin (Upstate), -β-catenin, -anti-α active β-catenin (αABC) (Upstate), -p-Akt (Santa Cruz), -Pan-Ras cloneRAS10 (Upstate), -p-Raf-1 serine 338 (Upstate), -p-MEK, -p-p38 (Cell Signaling Biotechnology), -p-ERK (Santa Cruz), -ERKs (Santa Cruz), -cyclin D1 (Santa Cruz), and -α-tubulin (Oncogene) primary antibodies were used followed by incubation with horseradish peroxidase-conjugated secondary antibody (Santa Cruz). Protein bands were visualized by enhanced chemiluminescence (Amersham Bioscience Pharmacia Biotech).
Foci Formation Assay-To evaluate anchorage-independent growth, 1.2 × 10 3 of L929-Axin-GFP cells were suspended in 1 ml of 0.3% molten top agarose (Life Technologies, Inc.) with or without 0.5 μg/ml of Dox, and overlaid onto 1 ml of 0.5% solid bottom agarose in 12-well plates. After solidification, the top layer of agarose was covered with 1 ml of culture medium with and without 0.5 μg/ml of Dox and, where required, 20 ng/ml of EGF was added. The colonies were maintained at 37 ℃ and periodically replenished with fresh medium containing Dox and/or EGF. Fourteen days after plating, colonies were examined under a phasecontrast fluorescence microscope for visualization of colonies expressing GFP. Whole-well images were captured using a Nikon digital camera and viewed using Adobe Photoshop 7.0 software. The average size of globes was calculated by averaging data (data were expressed as mean μm 3 ) from at least 150 colonies. Differences between groups were analyzed using the two-sample t test and were considered significant when the p-value was less than 0.05. In order to measure the effect of Axin in anchorage-independent ras-induced growth, NIH3T3-H-ras G12R cells (24) were transfected with pCS20MT-Axin for 24 h, 1.5 x 10 3 cells were then re-seeded into a 12-well soft argar plate, as described above, and H-ras G12R was induced with Dox, also as described above.
Cell Cycle and Quantitative Proliferation
Analyses-The cell cycle was analyzed by fluorescence-activated cell sorting (FACS) as previously described (24) . L929-GFP-Axin cells were grown to 60% confluence in 6-well plates and were arrested with double thymidine blocking for 12 h. Cells were then either untreated or treated with 0.5 of μg/ml Dox and/or 20 ng/ml of EGF at 12 h before FACS analysis. Cells were harvested, rinsed twice with PBS, fixed in 70% ice-cold ethanol, and then washed in PBS containing 1% FBS. Subsequently, DNA was stained with propidium iodide (BD Biosciences, Bedford, MA) for 30 min at 37 ℃. The cell cycle profile was determined using a Becton Dickinson FACS Caliber. Data were analyzed using the ModFit LT 2.0 program (Verity Software House, Inc., ME) and the WinMDI 2.8 program created by Joseph Trotter of Scripps Research Institute, CA. Error bars indicate the standard deviations of three independent analyses experiments. For quantitative analyses of proliferation, L929-GFP-Axin cells were transfected with pZIPRaf-CCAX (26) for 24 h followed by subsequent induction of Axin with 0.5 μg/ml of Dox for 24 h at 37 o C in 5% CO 2 . BrdU addition and measurements of the relative intensities of BrdU were performed as described previously (24) .
Cell Growth Measurement-Cell growth was determined by the number of viable cells. The cells were seeded into 6-well plates at 2 × 10 4 cells/well and the medium was replaced every day with fresh DMEM containing 10% FBS with or without 0.5 μg/ml of Dox. Where required, 20 ng/ml of EGF was added. For enumeration of viable cells, cells were trypsinized, washed once with PBS, and then total cell numbers of viable cells were counted using a hemocytometer.
BrdU Incorporation-For BrdU incorporation, L929 or NIH3T3-Ras cells were seeded onto 22×22 mm cover slips in 6-well plates at 2 × 10 4 cells per well. Cells were transiently transfected with pCS2-MT-Axin, pCS2-MT, Flag-β-cateinpcDNA3.0 or pcDNA3.0 and treated with 0.5 μg/ml of Dox for H-ras induction. Where required, BrdU (Boehringer Mannheim, Germany) was added at a final concentration of 20 μM at 36 h after transfection, and the cells were further incubated for 8 h at 37 . Cells were washed ℃ twice with PBS and then fixed in a methanol/formaldehyde (99:1) mixture at -20 ℃ for 20 min. Cells were permeabilized with 0.2% Triton X-100 at 4 for 30 min and then gently ℃ washed three times with PBS.
Cells were incubated with mouse anti-BrdU monoclonal antibody (DAKO, Carpinteria, CA) at a 1:100 dilution for 2 h at room temperature, incubated with goat anti-mouse-Cy TM 2-conjugated secondary antibody at a 1:1000 dilution for 1 h at room temperature, and then washed 5 times with PBS. For nuclear staining, 4'6'-diamidine-2'-phenylindole dihydrochloride (DAPI; Boehringer Mannheim) was used at a final concentration of 1 μg/ml in PBS for 10 min followed by extensive washing with PBS. Coverslips were mounted and then cells were viewed using a Radiance 2000/MP multi-photon imaging system (Bio-Rad). Each analysis was performed at least three times.
Measurement of Ras Activation-The capacity of Ras-GTP to bind the Ras binding domain (RBD) of Raf-1 was used to determine the level of GTP-bound Ras, as described previously (24) .
Reporter Analysis-For reporter gene assays, L929-GFP-Axin cells were seeded into 6-well dishes at 2 × 10 4 cells per well. Transfection efficiencies were determined by transfecting cells with 50 ng of the β-gal reporter plasmid, pCMV β-gal (Clontech). L929-GFP-Axin cells were cotransfected with 0.5 μg pElk-1, 0.5 μg of pFR-Luc, and 25 ng of pFA2-Elk-1. At 48 h after transfection, cells were harvested and luciferase assay were performed in triplicate from independent cell cultures as described previously (24) .
Immunocytochemical Staining-For immunocytochemical staining, L929-Axin-GFP cells were seeded at 2×10 4 cells/well in 6-well plates on 22×22 mm cover slips and cultured for 24 h at 37 o C in 5% CO 2 . The cells were treated with 0.5 μg/ml of Dox. Induced L929-Axin-GFP cells were fixed for 15 min at room temperature with 3.7% paraformaldehyde in PBS at pH 7.4, permeabilized for 30 min on ice with 0.2% Triton X-100 in PBS, and blocked with 1% BSA overnight at 4 o C. The antibody and DAPI reactions used same fluorescence staining method. Following several washing with PBS, the slides were mounted in a mounting medium. Tissues and cells were imaged using a Radiance 2100 laser scanning confocal microscope, and operated by Lasersharp 2000 software (BIO-RAD). A minimum of three 0.5 μm Z slices were acquired for each tissue and cell.
RESULTS

Axin Inhibits the ERK Pathway and Alters the
Morphology of L929 Fibroblasts-The role of Wnt/β-catenin signaling in ERK pathway regulation was investigated by examining the effects of Axin on the activities of the ERK pathway components. For this purpose, we generated L929 cells expressing Axin by a Doxinducible system (L929-GFP-Axin).
Upon treatment with Dox, expression of GFP-Axin was evident in L929-GFP-Axin cells after 2 h and was sustained up to 8 h post-induction (Fig. 1A) . There was a concomitant reduction in β-catenin protein levels and ERK phosphorylation upon GFP-Axin induction (Fig. 1A) . The phosphorylation of upstream regulators of ERK, such as Raf-1 and MEK, were also reduced by GFP-Axin induction (Fig. 1B) . Phosphorylation of the ERK pathway components and the level of β-catenin were restored in cells grown in fresh Dox depleted medium (Fig. 1B, left panel) , indicating that coregulation of β-catenin and ERK signaling is a reversible process. The β-catenin and ERK pathway components were not affected by induction of GFP in L929-GFP cells (Fig. 1B,  right panel) . The levels of phosphorylated Raf-1, MEK, and ERK were elevated in cells expressing increased levels of β-catenin due to Axin siRNA (Fig. 1C) , confirming the negative role of Axin in ERK activation. The level of endogenous Axin was low due to rapid protein turnover (30) , but the low level was detectable when the protein extracts were enriched by immunoprecipitation (Fig. 1C) .
Murine L929 cells display fibroblast morphology characterized as the polygonal/cuboidal phenotype with projection of long, sharp spikes at the cellular periphery. GFP expression alone did not significantly change the cellular morphology ( Fig. 2 ; left two panels). However, expression of GFP-Axin resulted in an altered cellular morphology characterized by a spindle (bipolar) or globular shape ( Fig. 2 ; right two panels). L929-GFP-Axin cells that failed to express GFP-Axin upon Dox treatment (marked by red arrows) retained the typical polygonal morphology of L929 cells (Fig. 2) .
Axin Inhibits the G1 to S Phase Cell Cycle Progression and Growth of L929 Fibroblast Cells
Stimulated by EGF-To determine whether Axin affects proliferation via the ERK pathway, we measured the effect of Axin expression on G1 to S phase cell cycle progression stimulated by EGF. EGF treatment increased the proportion of cells in the S phase from 43% to 58% (Fig. 3A) . The increase was abolished after introduction of GFPAxin ( Fig. 3A ; represent data are shown lower panel). EGF with 96 h post-treatment increased the cell numbers 3-fold compared with the untreated cells ( Fig. 3B; upper panel) . However, the Dox-induced growth stimulation was reduced 70% in cells expressing GFP-Axin ( Fig. 3B ; upper panel). Treatment of L929-GFP cells with Dox alone did not affect the cell number ( Fig. 3B ; lower panel), indicating that Dox alone does not inhibit L929 cell growth.
Axin Inhibits EGF-induced Activation of the ERK Pathway in L-929 Fibroblast Cells and in
Primary Hepatocytes-To confirm the role of the ERK pathway in anti-proliferation by Axin, we monitored the effect of Axin induction on activations of ERK pathway components. The phosphorylation levels of Raf-1, MEK, and ERK kinases that were concomitantly increased upon EGF treatment were reduced by GFP-Axin induction followed by a 2 h Dox treatment (Fig.  4A, upper panel) . The effects of Axin on the EGF-induced activation of ERK signaling were further potentiated by the sustained Dox treatment up to 8 h, despite the presence of EGF. Elk-1-mediated reporter gene activation by EGF was also reduced upon Axin induction (Fig. 4A, lower  panel) . Therefore, Axin inhibits the ERK pathway activation that is caused by EGF. We also observed a minor increase in β-catenin protein levels at 2 h after EGF treatment, which was reduced by GFP-Axin induction (Fig. 4A, upper  panel) .
To examine the effect of Axin on ERK pathway regulation under a more physiologically relevant condition, we used primary hepatocytes in measuring the Axin effect on ERK pathway regulation. The endogenous β-catenin was mostly localized at the cell-cell boundaries, and was mostly eliminated in cells overexpressing Axin by transient transfection (Fig. 4B , left panel; cells producing Axin in particulate forms are marked by a white arrow), indicating the functionality of transfected Axin in primary hepatocytes.
Phosphorylation of Raf-1, MEK, and ERK kinases, and β-catenin protein levels were concomitantly increased after EGF treatment, but were reduced in cells with overexpressed Axin (Fig. 4B, right  panel) . Cyclin D1 expression, which is subject to regulation by both the Wnt/β-catenin and ERK signaling pathways (31) was increased by EGF treatment, and again was significantly reduced by Axin overexpression. Again, endogenous Axin was only detected only after enrichment by immunoprecipitation.
The showing that β-catenin is required for ERK pathway inhibition by Axin. The β-catenin in HepG2 that lacks a potential phosphorylation site for GSK-3β (34) is detectable as two bands by using anti-β-catenin antibody when visualized by Western blot analyses (Fig. 5A ). We also investigated the effect of Axin induction on Ras protein by immunocytochemical analysis. Ras protein overexpressed by the retroviral transfection system was mostly localized in the cytoplasm and membrane area of L-929-GFPAxin cells (Fig. 5B) . The level of Ras protein overexpressed was step-wisely decreased by increasing the Axin induction time upto 24 h. The Ras protein was remained only in the peri-nuclear area of cells at 24 h after induction with Dox (Fig.  5B ). To provide clear evidence for the regulation of the Ras protein level by Axin, we measured the effects of β-catenin knock down in HCT-116 cells retaining mutated β-catenin (Fig. 5C ). The levels of Ras and active ERK pathway components (pRaf-1, p-MEK and p-ERKs) were simultaneously decreased by siRNA-mediated reduction of β-catenin. Here, Axin did not affect the level of Ras or the activities of the ERK pathway components (Fig. 5C ). Finally, Ras regulation was not observed in HCT-116 cells overexpressing β-catenin-S33Y, a non-degradable form of β-catenin (Fig. 5D) . Therefore, regulation of the β-catenin protein level is an essential factor in the regulation of Ras and ERK pathway components. Although β-catenin is involved in Ras regulation, neither the Ras protein level nor the ERK activities were increased by β-catenin-S33Y.
Suppression of the ERK Pathway by Axin Occurs at Least Partly via the Reduction of the Ras Protein Level-We measured the effect of
Axin overexpression on Ras activation to further characterize the involvement of Ras, the upstream component of the ERK pathway, in ERK pathway regulation by Axin. The Ras activity monitored by GTP-loading of Ras (Ras-GTP) was significantly increased by H-ras L61 overexpression, and was inhibited by Axin co-expression in Chang cells but not in HepG2 cells, which retain wild-type and mutant β-catenin, respectively (Fig. 6A , compare left and right panels). The reduction of GTP-ras L61 , the GTP-bound form of non-hydrolysable ras L61 (35) , by Axin, was surprising and indicated the possibility of the regulation of ras according to protein level. The level of Pan-Ras, which was increased by H-ras L61 overexpression, was reduced by Axin co-expression, and that also occurred in Chang cells but not in HepG2 cells (Fig. 6A , compare left and right panels). The fold regulations of Ras protein levels by Axin, however, were much lower than that of Ras-GTP by Axin. The increases in the levels of GTP-Ras and Ras by H-ras L61 overexpression were similarly reduced by Axin co-overexpression in NIH3T3 cells that also retained wild-type β-catenin (data not shown; Supplement Fig. S1 ). The level of endogenous Ras was also reduced by Axin overexpression in Chang, DLD-1, SW-480 cells (Fig. 5A) as well as in primary hepatocytes (Fig. 4B) . By contrast, endogenous Ras levels were not reduced in HepG2 and HCT-116 cells that retained mutated β-catenin (Fig. 5A) . Akt is one of the Ras affectors (36) ; accordingly, the pAkt level was increased by ras L61 and blocked by Axin induction (Fig. 6A) . The patterns of p-Akt regulation by ras L61 and Axin are similar to those by β-catenin and Ras. Akt regulation by Axin or Ras, however, was not observed in cells retaining mutant β-catenin (Fig. 6A, right panel) . The level of p-Akt was not increased by ras L61 in HepG2 cells by unknown mechanism, but that did not affect the quality of the results (Fig. 6A, right  panel) .
EGFR Is Involved in the Regulation of Ras and the ERK Pathway Components by Axin-To
identify the involvement of EGFR in Ras regulation by Axin, we measured the effects of EGFR siRNA (Fig. 6B) . The p-EGFR levels, which were detected only after enrichment by immunoprecipitation of EGFR, were increased by 10 min stimulation with EGF in L929 cells, indicating the functionality of EGF. It was noticeable that the Ras protein level did not change, although the p-Raf-1, p-MEK and pERKs levels were increased by 10 min EGF treatment. Interestingly, we noticed an increase of non-phosphorylated β-catenin by immediate EGF signaling (Fig 6B, right panel) using anti-α-active β-catenin (ABC) antibody. Anti-ABC antibody recognizes non-phosphorylated Ser37 and Thr-41 of β-catenin, which forms are resistant to proteosomal degradation (37) . That the level of β-catenin was only slightly increased might have been due to the short EGF treatment time. The increment of p-EGFR by EGF was reduced by Axin induction. The levels of non-phosphorylated β-catenin, Ras, as well as the activities of the ERK pathway components, which were increased by EGF, were reduced by both induction of Axin and treatment of EGFR siRNA (Fig. 6B) . Notably, we also observed reductions of both β-catenin and non-phosphorylated β-catenin by EGFR siRNA. We did not observe any changes in the levels of pp38 under any of these conditions (Fig. 6B) , which indicates specificity in the regulation of the β-catenin and ERK pathway components by EGFR, Axin etcetera.
The Lysosomal Protein Degradation Machinery Is Involved in Ras Regulation by Axin-A recent study by Bar-Sagi's group reported that mono-and di-ubiquitination of Ras is related to the endocytosis (38) . To determine whether the endocytosis involves lysosomal degradation of Ras, we investigated the effect of leupeptin, a lysosomal inhibitor, in the regulation of the Ras protein level. Both endogenous Ras and overexpressed ras L-61 which were reduced by Axin overexpression were abolished in cells treated with leupeptin (Fig. 7) . The lysosomal protein degradation machinery, then, is involved in Ras reduction by Axin.
Axin Inhibits ras
G12R -induced but not Raf-CAAXinduced Proliferation of L929 Fibroblast Cells-
To determine whether Axin can inhibits cellular proliferation and ERK pathway activation induced by Ras, we measured the effect of Axin transfection on BrdU incorporation stimulated by Dox-mediated induction of H-ras G12R in NIH3T3 fibroblast cells (39) . The relative numbers of BrdU positive cells were increased from 32% to 49% by H-ras G12R induction, but that increment was mostly abolished by transfection of the Axin gene (Fig. 8A) . The proliferation of L929 cells was also increased by β-catenin transfection, but was reduced by co-transfection of Axin (Fig. 8B) , indicating as expected, that Axin inhibits proliferation induced by β-catenin. To further characterize a functional point of Axin in antiproliferation by Axin, we measured the effects of Axin overexpression on the proliferation induced by Raf-CAAX, active Raf. The proliferation induced by overexpression of constitutively active Raf-1, Raf-1-CAAX, was not reduced by Axin induction (Fig. 8C) , suggesting that Axin regulates the ERK pathway and proliferation upstream of Raf-1.
Axin
Inhibits EGF-induced Anchorageindependent Growth of Fibroblasts-To determine whether Axin affects cellular transformation induced by ERK pathway activation, we measured the effect of GFP-Axin expression on colony formation induced by EGF. Under the no-EGFstimulation condition, the colony numbers formed by Axin-GFP-expressing cells were reduced by approximately 40% when compared with the numbers of control cells transfected with empty vector (Fig. 9) . In addition, the size of colonies formed in GFP-Axin-expressing cells was reduced by approximately 45% ( Fig. 9 ; representative data are shown at right panel). Compared to untreated cells, both the number and size of colonies formed by EGF-treatment were increased approximately 2 folds, which were blocked by ectopic expression of GFP-Axin (Fig. 9) . Moreover, the colony sizes were observed to be inversely correlated to the intensity of GFP-Axin ( Fig. 9 ; right panel, compare middle and lower boxes).
DISCUSSION
Aberrant regulation of either the Wnt/β-catenin or the ERK pathway has been known to be implicated in many types of human cancers. However, the interaction between the two pathways in carcinogenesis is poorly understood. A defective apc allele and an activated ras gene are sufficient to transform normal colonic epithelial cells and render them carcinogenic (40) . β-catenin has been shown to cooperate with ras in the development of CRC and HCC (22, 23) .
Simultaneous introduction of β-catenin and ras mutations into mice resulted in the development of HCC in 100% of tested animals, although neither ras nor β-catenin alone was sufficient for hepatocarcinogenesis (23) . These results indicate that Wnt/ β-catenin and ERK signaling experience cross-talk during carcinogenesis, however, the molecular details how the two pathways can interact each other remain poorly elucidated.
In this study, we investigated a mechanism for the Ras-ERK pathway regulation by Wnt/β-catenin signaling by modulating of the negative regulator Axin, and related that mechanism to cellular proliferation and transformation. The ERK pathway components (Raf-1, MEK and ERK kinases) were simultaneously lowered in cells in which the β-catenin level was reduced by Axin overexpression, indicating that Axin inhibits the Raf-1 MEK ERK cascade. Both EGF-induced G1 to S phase progression and growth of L929 cells were also reduced by Axin overexpression, providing further evidence for the role of Axin in suppression of the cell growth that is controlled by the ERK pathway. The role of Axin in the inhibition of growth induced by ERK pathway activation was further indicated by reduction of ras-induced proliferation by Axin. The sizes and numbers of colonies of L929 cells grown on a soft agar plate in the presence of EGF were reduced by induction of Axin, indicating that Axin probably has an inhibitory function in transforming cellular growth induced by ERK pathway activation. The incidence of colony formation and the size of the formed colonies were both extremely low in the case of NIH3T3 cells compared with those of Lcells retaining transforming characteristics under identical growth conditions. Although the numbers were few, well developed small-sized colonies were formed by induction of H-ras G12R by Dox (24) . The H-ras G12R -induced colony formation was blocked by transfection of Axin (Supplemental Fig. S2 ), confirming the role of Axin in anti-transformation of cells induced by oncogenic ras.
The effects of Axin on the ERK pathway regulation was confirmed in similar analyses of primary hepatocytes, providing physiologically relevant evidence for down-regulation of the ERK signaling pathway by Axin. Inhibition of the ERK pathway components by Axin transfection occurred only in cells retaining wild-type β- Currently, a mechanism for the ERK pathway regulation by Axin has yet to be clearly illustrated. The ERK activation by ras L61 or β-catenin was lowered by dominant negative Tcf-4 (24,41), indicating involvement of β-catenin/Tcf mediated gene transcription in the ERK pathway regulation by Wnt/β-catenin signaling. The level of Ras-GTP was reduced by Axin overexpression, indicating that the Raf-1 MEK ERK regulation by Axin-β-catenin signaling occurs via Ras. Interestingly, the level of GTP bound overexpressed nonhydrolysable ras L-61 was also reduced by Axin overexpression, providing us an opportunity for identification of the regulation of the ras protein level by Wnt/β-catenin signaling. Evidence for the Ras regulation by Axin was also provided by the reductions of the levels of endogenous Ras by Axin overexpression. A role of β-catenin in the regulation of the Ras protein level was also revealed by β-catenin-dependent degradation patterns in Ras regulation by Axin ( Fig. 5A; Figs. 5C and 6A). The Ras regulation by Axin was further confirmed by regulation of an activity of Akt, a known effecter of Ras (36) , as well as the fact that the Akt regulation also occurred in cells retaining wild-type β-catenin (Fig. 6) . The role of β-catenin in the regulation of Ras by Axin was also shown by regulation of the ras level and activities of the ERK pathway components by knock down of endogenous non-degradable mutant β-catenin (Fig. 5C ). The loss of both Ras and ERK regulation by Axin in HCT-116 cells overexpressing non-degradable β-catenin S33Y further confirms the essential role of β-catenin in Ras regulation by Axin (Fig. 5D) . Overall, the ERK pathway is subjected to dual Ras regulation, GTP-loading and Ras reduction by Axin. The theory explaining the dual regulation of Ras by Wnt/β-catenin signaling was supported by differences in the regulation folds between the Ras level and the activities of the ERK pathway components (Fig. 6A) . The fold regulations of the ERK activities were much higher than those of the Ras protein level, but similar to those of Ras-GTP. The level of Ras-GTP determines the fold regulation of the ERK pathway because it represents the cumulative activity of Ras caused by regulation of GTP loading as well as by the level of Ras.
Currently, routes for regulations of the reduction and GTP loading of Ras are not clear. The regulation of GTP loading of Ras by Wnt/β-catenin signaling might be caused by the signal from upstream of Ras, and that explanation was supported by the recent identification of the epidermal growth factor receptor (EGFR) gene as a transcriptional target of Wnt/β-catenin signaling (42) . However, we suggest that the major functional point of Axin in the regulation of the ERK pathway is Ras rather than EGFR. Axin inhibits Raf-1 MEK ERK cascade in cells retaining mutated ras as well as wild type Ras, indicates that Axin regulates Ras at least partly at its own level or its downstream. The ras L61 -induced proliferation was totally abolished (Fig.  8A ), but the proliferation induced by constitutively active Raf-CAAX was not affected by Axin overexpresion (Fig. 8C) . These epistasis results further indicate that a functional point of Axin in the regulation of the ERK pathway is Ras. We observed regulation of Ras by EGFR siRNA, however, that might be attributed by β-catenin regulation, as indicated by the concomitant reductions of β-catenin and Ras by EGFR siRNA (Fig. 6B) . It is unknown how EGFR is involved in regulation of β-catenin, however, a previous study reported EGFR−β-catenin interaction without providing any information for cross-talk between Wnt/β-catenin and Ras-ERK pathways (43). The mechanism for Ras reduction by β-catenin signaling has also not been illustrated currently. However, a recent study has reported mono-and di-ubiquitination of Ras protein involving the endocytic pathway (38) . The Ras reduction by Axin is potentially regulated by the lysosomal protein degradation machinery as indicated by inhibition of the Axin-induced Ras reduction by leupeptin in our current study.
In this study, we identified regulations of the Ras-ERK pathway and cellular proliferation and transformation by Wnt/β-catenin signaling involving Axin and its effector, β-catenin. The identification of Ras-ERK pathway regulation by Wnt/β-catenin signaling provides evidence for the role of the Ras-ERK pathway in tumorigenesis induced by abnormalities in Wnt/β-catenin signaling. EGF at 20 ng/ml was added to cells 2 h before harvesting. Cells were harvested 48 h post-transfection, and relative reporter activities were measured by a luciferase assay. Each data point represents the average of three independent analyses. Error bars indicate the standard deviations of three independent analyses. B, Left, Primary hepatocytes were transfected with pCS2-MT-Axin for 48 h. The cells were then treated with anti-β-catenin and anti-Axin antibodies. β-Catenin proteins were detected as a red color using anti-mouse-Rhodamine Red TM , Axin proteins were detected as a green color using anti-mouse-FITC. The cell nuclei were stained with DAPI. Samples were mounted for photography on confocal microscope as described in Experimental procedures. Bar, 10 μm. Right, Primary hepatocytes were transfected with pCS2-MT or pCS2-MT-Axin for 48 h. Cells were then untreated and treated with 20 ng/ml of EGF 2 h before harvesting. Western blot analysis was performed to detect  β-catenin, p-Raf-1, p-MEK, p-ERK, ERKs, Pan-Ras, Cyclin D1 and α-tubulin. Axin was detected by immunoprecipitation (IP) of 400 μg of whole-cell lysate followed by detection by Western blot analysis. . The GTP-loading analysis was performed to detect GTPbound Ras (Ras-GTP), as described in Experimental procedures. The levels of PanRas-GTP, p-ERK, Axin, β-catenin, Pan-Ras, p-Akt and α-tubulin were detected by Western blot analyses. B, Effect of EGFR siRNA on β-catenin and Ras-ERK pathway regulation by Axin. L929-GFP-Axin cells were transfected with control or EGFR siRNA. The cells were treated with 0.5 μg/ml of Dox and/or 20 ng/ml of EGF for 12 h and 10 min, respectively, before harvesting them in the required case. The level of Axin, p-EGFR, Pan-Ras, p-Raf-1, p-MEK, p-ERK, ERK, β-catenin, αABC (α-active β-catenin) (37), or pp38 was detected by Western blot analyses. The p-EGFR blot was obtained by Western blot analyses with the samples immunoprecipitatied by 2 μg of anti-EGFR antibody against 600 μg of total lystates with Protein A bead. The cells were harvested at 24 h after transfection. In required cases, 10 μg/ml leupeptin was treated for 12 h before harvest cells. Pan-Ras, p-ERK, Axin, and α-tubulin were detected by Western blot analyses. 
